Anthera Pharmaceuticals Stock Price and Value Analysis

Should you buy Anthera Pharmaceuticals stock? (Other OTC:ANTH). Let's see how it does in our automated value investing analysis system.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Anthera Pharmaceuticals to reach your target.

Target type
AdvantagesDisadvantagesNeutral
  • This company is solid.
  • This stock looks overpriced.
  • This company has wild ups and downs.
  • This company is not making money.
  • This company pays no dividend.

Inside the ANTH Numbers

ANTH Price
(Anthera Pharmaceuticals stock price per share)
$0.00
[?] PE Ratio versus Sector 100% lower than other Unknown stocks
[?] PE Ratio versus Industry 57.8% higher than other Unknown stocks
[?] Cash Yield -500161.86%
[?] Free Cash Flow Jitter 74%

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

Continue Learning: Value Investing Guides

Is Anthera Pharmaceuticals Stock on Sale?

Based on our analysis, we believe that you should not buy Anthera Pharmaceuticals right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Advertisement supports free stock analysis content.

Should You Buy ANTH Stock?

Does Anthera Pharmaceuticals have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: ANTH

This example shows how we apply the Trendshare checklist to ANTH: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 0.00
    • Market cap: $2617
    • EPS: -0.01
  2. Step 2 — Valuation checks

    • P/E:
    • FCF yield: -1180741.3%
    • Date checked: Dec 25, 2025
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.
Illustrative sparkline of recent price-like movements (not an actual price series). The blue line shows a simplified trend; the gray baseline is a notional recent level. This graphic is a visual aid only — use the numeric values in the steps above for decisions.